NCT02643329View on ClinicalTrials.gov

Clinical Bioequivalence Study on Two Gliclazide 80mg Tablet Formulations

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

March 31, 2016

Study Completion Date

April 30, 2016

Conditions
Healthy
Interventions
DRUG

BF-Gliclazide Tablet 80mg

BF-Gliclazide Tablet is a generic product manufactured by Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited

DRUG

Diamicron 80mg Tablet

Diamicron 80mg Tablet is manufactured by Les Laboratoires Servier Industrie, France

Trial Locations (1)

Unknown

Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, New Territories

All Listed Sponsors
collaborator

Chinese University of Hong Kong

OTHER

lead

Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited

INDUSTRY

NCT02643329 - Clinical Bioequivalence Study on Two Gliclazide 80mg Tablet Formulations | Biotech Hunter | Biotech Hunter